Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The broader enforcement focus: Botox-type products, ophthalmics, clinical trials, recalls The RAPS article also highlights other key enforcement priorities for CDER in 2025: The agency issued 18 warning letters to firms marketing fraudulent or unapproved Botox-type products, warning that such products pose serious safety risks, including potential counterfeiting, incorrect/inactive ingredients, or falsification
If you serve yourself the same plate you ate before starting, it may suddenly look too big
SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care
The company entered a pact with its diabetes partner Vitae Pharmaceuticals in June 2009, to explore beta-secretase (BACE) inhibitors for the treatment of Alzheimers disease
9 Is Lmethylfolate supplementation effective
